Public filings / DRUG on Yahoo Finance (opens in a new tab)
DRUG: insider buying, 13F holders, analyst moves
Bright Minds Biosciences Inc - US
A summary of public filings about Bright Minds Biosciences Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
3 of our 100 managers hold DRUG
Combined reported value $39.1M; 1 sold out since Q1 2026.
Holders among our 100 managers: 0 in Q3 2023, 3 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Deerfield Company | $19.9M | 0.21% | Unchanged |
| RA Capital | $18.6M | 0.16% | Unchanged |
| Tudor Investment | $582K | 0.00% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.